Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Metal-Ion-Chelating L-Phe Nanostructures Enhance ICB
2026-08-14
A Nature Nanotechnology study developed metal-ion-chelating L-phenylalanine nanostructures that reprogram dendritic-cell ion signaling and remodel immunosuppressive tumour microenvironments. When paired with short-term starvation, these materials improved dendritic-cell maturation, tumour-specific cytotoxic T-cell responses, and sensitivity of breast and colorectal tumour models to immune checkpoint blockade.
-
Recombinant Annexin V for Apoptosis Detection
2026-08-13
Brumatti, Sheridan, and Martin established a practical workflow for expressing, purifying, and fluorescein-labeling recombinant annexin V as a probe for phosphatidylserine externalization. The method supports rapid flow-cytometric and microscopic detection of apoptotic membrane changes while clarifying why calcium dependence, membrane integrity, and assay interpretation must be considered together.
-
Nystatin (Fungicidin) Research Workflows
2026-08-13
Build reproducible Candida assays with Nystatin (Fungicidin), from DMSO stock preparation and MIC testing to adhesion, biofilm, and combination studies. A 2024 reference study also shows how ergosterol modulation can sharpen polyene experiments, while formulation and assay controls help distinguish true antifungal activity from solubility artifacts.
-
Macrophage Mertk in Angiotensin II Heart Failure
2026-08-12
The reference study identifies macrophage Mertk as an unexpected driver of pressure overload-induced cardiac hypertrophy and heart failure. Its mechanistic model links efferocytosis of apoptotic cardiomyocytes to mitochondrial double-stranded RNA, macrophage TLR3 activation, type I interferon signaling, and impaired cardiomyocyte mitophagy.
-
(-)-Blebbistatin Workflow for Myosin II Studies
2026-08-12
Use (-)-Blebbistatin as a reversible, cell-permeable probe to separate actomyosin-dependent mechanics from electrical or morphological signals. This workflow connects cytoskeletal assays with panoramic cardiac opto-electrical mapping while emphasizing dose finding, vehicle controls, washout, and motion-artifact troubleshooting.
-
Resveratrol: A Mechanism-First Neuroprotection Guide
2026-08-11
Resveratrol is a widely used SIRT1 activator with potential to connect mitochondrial biogenesis, oxidative-stress control, and apoptosis assays. This guide translates the 2024 N2a-cell evidence into a mechanism-first framework for designing and interpreting neuroprotection experiments.
-
Mitochondrial Calcium Signaling and Ferroptosis
2026-08-11
The reference study identifies mitochondrial calcium uptake through MCU as a metabolic regulator of GPX4 activity and ferroptosis resistance. Its combination of mouse genetics, cancer models, structural analysis, and GPX4 mutagenesis suggests that calcium-dependent acetyl-CoA signaling sustains lipid peroxide detoxification and may influence tumor sensitivity to ferroptotic stress.
-
Dual-Action Inhibitors and p38α Dephosphorylation
2026-08-10
The reference preprint shows that selected kinase inhibitors can do more than block p38α MAPK catalysis: they can also accelerate WIP1-mediated dephosphorylation of the kinase activation loop. Structural and biochemical data support a mechanism in which inhibitor-stabilized activation-loop conformations expose the regulatory phospho-threonine, suggesting a route to more durable and potentially more selective kinase pathway control.
-
Losmapimod: Reading p38 Signaling in Context
2026-08-09
Losmapimod and GW856553X provide a useful framework for studying p38α/β-driven inflammatory signaling without confusing kinase inhibition with phosphatase-mediated signal termination. This article translates recent structural evidence into assay-design decisions for vascular, hypertension, and COPD research.
-
Lactobacillus acidophilus–UDCA Axis in Ulcerative Colitis
2026-08-08
Deng et al. show that Lactobacillus acidophilus (LA) can alleviate experimental ulcerative colitis through a microbiota-dependent increase in ursodeoxycholic acid (UDCA). The study connects this metabolite to two coordinated immune effects—enhanced regulatory T-cell differentiation and reduced M1 macrophage polarization—while identifying RapGap/PI3K-AKT/NF-κB signaling as a mechanistic pathway.
-
Cell Divisions Refine Drosophila Tissue Boundaries
2026-08-07
A 2026 Development study shows that cell division has dual mechanical effects at the Drosophila mesectoderm–ectoderm boundary: it can promote mixing when actomyosin tension is weakened, yet sharpen the interface under normal conditions. Mathematical modelling, division perturbation, laser ablation, and live cell tracking reveal that proliferation increases ectodermal fluidity and supports boundary refinement.
-
ATRX-Deficiency Sensitizes Glioma Cells to RTK/PDGFR Inhibit
2026-08-07
This study demonstrates that high-grade glioma cells lacking ATRX are more vulnerable to receptor tyrosine kinase (RTK) and PDGFR inhibitors, suggesting a molecularly targeted therapeutic avenue. The findings emphasize the importance of integrating ATRX status into clinical trial stratification for glioma treatments.
-
LGK-974: Precision PORCN Inhibitor for Wnt Pathway Research
2026-08-06
LGK-974 is a benchmark PORCN inhibitor that enables targeted Wnt pathway modulation, supporting breakthroughs in cancer biology and regenerative medicine. This guide delivers actionable protocols, troubleshooting insights, and real-world applications for maximizing the compound's impact in Wnt-driven cancer and developmental models.
-
(-)-Blebbistatin: Unlocking Non-Muscle Myosin II in Cardiac
2026-08-06
Explore the unique role of (-)-Blebbistatin as a non-muscle myosin II inhibitor in dissecting cellular mechanics and cardiac function. This article reveals advanced assay strategies and integrates new insights from recent temperature-sensing cardiac research.
-
U3 snoRNA and DDX21 Interplay Regulates Mitosis in the PR
2026-08-05
This study reveals that U3 snoRNA and DDX21 interact dynamically in the perichromosomal region (PR) to orchestrate mitotic progression. Using advanced labeling and imaging, the research uncovers their interdependent localization, mechanistic roles in phase separation, and implications for mitotic regulation.